Risk factors for ocular chlamydia after three mass azithromycin distributions.

ABSTRACT:

Background

An important component of the World Health Organization's comprehensive trachoma elimination strategy is the provision of repeated annual mass azithromycin distributions, which are directed at reducing the burden of ocular chlamydia. Knowledge of characteristics associated with infection after mass antibiotic treatments could allow trachoma programs to focus resources to those most likely to be infected with ocular chlamydia.

Methodology/principal findings

We monitored 12 communities in rural Ethiopia that had received 3 annual mass azithromycin treatments as part of a cluster-randomized trial for trachoma. One year after the third treatment, a random sample of children from each village received conjunctival examination for follicular trachomatous inflammation (T

SUBMITTER: Ayele B 

PROVIDER: S-EPMC3236733 | biostudies-literature | 2011 Dec

REPOSITORIES: biostudies-literature